Corporate India is stepping up to shoulder coronavirus-induced challenges by lending a helping hand through various initiatives like testing, vaccination camps, financial aid, medical help and resource access for COVID-19 care. As the country battles with the second wave of the pandemic, companies are tweaking policies on loans, insurance and leaves to help employees take care of themselves and their families. Apart from facilitating vaccination appointments and paid vaccination leaves, many corporates have updated the group Mediclaim policy to cover COVID-19-related expenses for employees and their families. We are offering COVID-19 Kavach policies for employees and their family members to meet COVID-related medical expenses, in addition to Group Term and Mediclaim cover, said Kristyl Bhesania, executive vice-president and head (human resources) at Tata AIA Life Insurance.
Bajaj Healthcare has announced the launch of Ivejaj (Ivermectin) an Anti Parasitic Drug now widely used in control & treatment for Covid-19 patients. The company has received approval from India s drug regulator, to manufacture and market Ivejaj the oral Ivermectin approved medication in India for the treatment of COVID-19 from 6 May 2021.
IVEJAJ Tablets comprising Ivermectin. Ivermectin is an Anti-Parasitic Drugs, which is used to control parasitic roundworm infections and curing parasitic infections, helps to improve health of Covid-19 Patients.
It works by paralyzing and killing parasites.
The company has successfully developed the active pharmaceutical ingredient (API) and the formulation for Ivermectin through its own in-house R&D team. Most patients ailing from mild to moderate symptoms can benefit from the use of Ivejaj. The drug will be available as a prescription-based medication, with recommended doses.
Read more about Adani Total Gas Q4 PAT rises 19% to Rs 145 cr on Business Standard. Adani Total Gas consolidated net profit jumped 18.6% to Rs 144.82 crore on 26.4% surge in net sales to Rs 584.48 crore in Q4 FY21 over Q4 FY20.
Read more about Adani Enterprises consolidated net profit rises 282% in March quarter on Business Standard. Adani Enterprises on Wednesday reported 282.2 per cent rise in consolidated net profit at Rs 233.95 crore for the quarter ended March 31, 2021.
On a consolidated basis, Adani Ports & Special Economic Zone (APSEZ) posted 285% jump in net profit to Rs 1287.80 crore on 21.1% rise in total income to Rs 4072.42 crore in Q4 FY21 over Q4 FY20.On a consolidated basis, profit before tax soared by 500% to Rs 1539 crore in Q4 FY21 as against Rs 256.73 crore in Q4 FY20. The company s operating revenue grew 24% year on year to Rs 3,608 crore in Q4 FY21. EBITDA (excluding forex gain of Rs 24 crore in Q4 FY21 versus forex loss of Rs 1,004 crore in Q4 FY20) jumped 39% year on year to Rs 2287 crore in Q4 FY21.
Port revenue increased 30% to Rs 3123 crore in Q4 FY21 while revenue from logistics business declined 7% to Rs 268 crore in Q4 FY21 over Q4 FY20. The company s cargo volume surged 27% year on year to 73 MMT in Q4 FY21 as against 58 MMT in Q4 FY20.